Viltepso 250 MG per 5 mL Injection
- RxCUI
- 2389849
- RxNorm name
- Viltepso 250 MG per 5 mL Injection
- Display name
- Viltepso 250 MG per 5 mL Injection
- Full name
- Viltepso 250 MG per 5 mL Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Viltepso | VILTOLARSEN | NS Pharma, Inc. | 1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123 | 2025-07-16 | Warnings, Adverse reactions | 2389849 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1ffff9a8-6d6a-4dcb-8493-1b6cc3a5d123 | VILTEPSO 250 MG in 5 mL Injection [PSN] · 5 ML viltolarsen 50 MG/ML Injection [Viltepso] [SBD] · 5 ML Viltepso 50 MG/ML Injection [SY] · Viltepso 250 MG per 5 mL Injection [SY] | 4 | 7 | These highlights do not include all the information needed to use VILTEPSO ® safely and effectively. See full prescribing information for VILTEPSO. VILTEPSO (viltolarsen) injection, for intravenous use Initial U.S. Approval: 2020 | 20250716 |